FARALLON CAPITAL MANAGEMENT LLC - Q3 2017 holdings

$11.3 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 85 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 69.1% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$1,642,542,000
+99.4%
6,538,000
+91.9%
14.60%
+70.6%
NXPI BuyNXP SEMICONDUCTORS N V$873,620,000
+24.2%
7,725,000
+20.2%
7.76%
+6.3%
TWX BuyTIME WARNER INC$862,834,000
+23.1%
8,422,000
+20.7%
7.67%
+5.4%
AABA SellALTABA INC$802,992,000
+18.6%
12,122,457
-2.5%
7.14%
+1.5%
BCR BuyBARD C R INC$507,993,000
+9.7%
1,585,000
+8.2%
4.52%
-6.1%
GOOG BuyALPHABET INCcap stk cl c$374,364,000
+34.1%
390,324
+27.1%
3.33%
+14.8%
DVMT BuyDELL TECHNOLOGIES INC$348,483,000
+47.5%
4,513,440
+16.7%
3.10%
+26.2%
WAB BuyWABTEC CORP$336,357,000
+14.4%
4,440,356
+38.2%
2.99%
-2.1%
PLYA  PLAYA HOTELS & RESORTS NV$319,230,000
-12.7%
30,606,9300.0%2.84%
-25.3%
FB SellFACEBOOK INCcl a$316,789,000
-9.1%
1,853,979
-19.7%
2.82%
-22.2%
Q SellQUINTILES IMS HOLDINGS INC$295,483,000
-15.2%
3,108,053
-20.2%
2.63%
-27.5%
V SellVISA INC$248,752,000
-6.1%
2,363,668
-16.3%
2.21%
-19.6%
CTXS BuyCITRIX SYS INC$223,436,000
+74.8%
2,908,562
+81.0%
1.99%
+49.5%
HDS SellHD SUPPLY HLDGS INC$196,010,000
+4.1%
5,434,168
-11.6%
1.74%
-10.9%
MSFT BuyMICROSOFT CORP$191,947,000
+12.7%
2,576,812
+4.3%
1.71%
-3.6%
KITE NewKITE PHARMA INC$175,213,000974,435
+100.0%
1.56%
RDUS BuyRADIUS HEALTH INC$151,744,000
-9.0%
3,936,300
+6.8%
1.35%
-22.1%
BIIB BuyBIOGEN INC$148,732,000
+157.9%
475,000
+123.5%
1.32%
+120.7%
FIS BuyFIDELITY NATL INFORMATION SV$147,051,000
+14.7%
1,574,586
+4.9%
1.31%
-1.9%
INFO BuyIHS MARKIT LTD$139,764,000
+13.7%
3,170,699
+13.6%
1.24%
-2.7%
ALR SellALERE INC$137,673,000
-36.9%
2,700,000
-37.9%
1.22%
-46.0%
EFX NewEQUIFAX INC$136,727,0001,290,000
+100.0%
1.22%
VRSK BuyVERISK ANALYTICS INC$136,083,000
+234.1%
1,635,807
+238.8%
1.21%
+186.1%
STZ SellCONSTELLATION BRANDS INCcl a$130,614,000
-3.8%
654,869
-6.6%
1.16%
-17.7%
VEON BuyVEON LTDsponsored adr$123,032,000
+54.0%
29,433,518
+44.0%
1.09%
+31.8%
TRU NewTRANSUNION$109,745,0002,322,158
+100.0%
0.98%
 HERBALIFE LTDnote 2.000% 8/1$108,286,000
-3.9%
108,177,0000.0%0.96%
-17.8%
AZN BuyASTRAZENECA PLCsponsored adr$107,738,000
+449.6%
3,180,000
+453.0%
0.96%
+369.6%
BUD NewANHEUSER BUSCH INBEV SA/NVsponsored adr$107,370,000900,000
+100.0%
0.95%
LBTYA SellLIBERTY GLOBAL PLC$101,490,000
-25.1%
2,992,935
-29.1%
0.90%
-35.9%
LBTYK SellLIBERTY GLOBAL PLC$101,036,000
-25.6%
3,089,773
-29.0%
0.90%
-36.3%
HUN SellHUNTSMAN CORP$95,970,000
-31.5%
3,500,000
-35.4%
0.85%
-41.4%
CPN NewCALPINE CORP$95,285,0006,460,000
+100.0%
0.85%
BMY NewBRISTOL MYERS SQUIBB CO$86,368,0001,355,000
+100.0%
0.77%
HLF SellHERBALIFE LTD$85,455,000
-42.9%
1,259,835
-40.0%
0.76%
-51.1%
SellSOLARCITY CORPnote 1.625%11/0$78,148,000
-42.4%
82,332,000
-42.5%
0.70%
-50.7%
GILD NewGILEAD SCIENCES INC$76,564,000945,000
+100.0%
0.68%
FOLD BuyAMICUS THERAPEUTICS INC$76,622,000
+153.6%
5,081,055
+69.4%
0.68%
+116.9%
AKRXQ NewAKORN INC$75,673,0002,280,000
+100.0%
0.67%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$69,506,000
-38.4%
191,255
-42.9%
0.62%
-47.2%
CMCSA SellCOMCAST CORP NEWcl a$67,018,000
-48.6%
1,741,621
-48.0%
0.60%
-56.0%
GNCMA BuyGENERAL COMMUNICATION INCcl a$67,051,000
+186.4%
1,643,800
+157.3%
0.60%
+145.3%
BRCD NewBROCADE COMMUNICATIONS SYS I$61,304,0005,130,000
+100.0%
0.54%
FGEN BuyFIBROGEN INC$59,180,000
+70.9%
1,100,000
+2.6%
0.53%
+46.1%
ABBV SellABBVIE INC$51,983,000
-14.1%
585,000
-29.9%
0.46%
-26.6%
ANTM  ANTHEM INC$39,875,000
+0.9%
210,0000.0%0.35%
-13.7%
SLD  SUTHERLAND ASSET MGMT CORP M$36,491,000
+5.7%
2,324,2360.0%0.32%
-9.5%
XLRN NewACCELERON PHARMA INC$35,939,000963,000
+100.0%
0.32%
GRFS BuyGRIFOLS S Asp adr rep b nvt$31,298,000
+37.2%
1,429,773
+32.4%
0.28%
+17.3%
ESV NewENSCO PLC$29,372,0004,920,000
+100.0%
0.26%
EXEL SellEXELIXIS INC$28,834,000
-22.7%
1,190,000
-21.5%
0.26%
-34.0%
GLPG NewGALAPAGOS NVspon adr$24,035,000236,216
+100.0%
0.21%
IONS NewIONIS PHARMACEUTICALS INC$22,815,000450,000
+100.0%
0.20%
LUMN NewCENTURYLINK INCput$21,622,0001,144,000
+100.0%
0.19%
SVRA  SAVARA INC$20,804,000
+59.0%
2,225,0000.0%0.18%
+36.0%
RYAAY SellRYANAIR HLDGS PLCsponsored adr ne$20,597,000
-19.9%
195,382
-18.2%
0.18%
-31.5%
SNI NewSCRIPPS NETWORKS INTERACT IN$20,184,000235,000
+100.0%
0.18%
SBAC SellSBA COMMUNICATIONS CORP NEWcl a$19,697,000
-86.2%
136,738
-87.1%
0.18%
-88.2%
ENTA NewENANTA PHARMACEUTICALS INC$19,297,000412,333
+100.0%
0.17%
MYOK NewMYOKARDIA INC$17,033,000397,500
+100.0%
0.15%
SPB NewSPECTRUM BRANDS HLDGS INC$15,570,000147,000
+100.0%
0.14%
HRG NewHRG GROUP INC$15,376,000985,000
+100.0%
0.14%
SAGE BuySAGE THERAPEUTICS INC$15,170,000
+90.5%
243,500
+143.5%
0.14%
+62.7%
AKBA  AKEBIA THERAPEUTICS INC$14,359,000
+36.9%
730,0000.0%0.13%
+17.4%
RGNX NewREGENXBIO INC$13,740,000417,000
+100.0%
0.12%
STML BuySTEMLINE THERAPEUTICS INC$13,181,000
+23.8%
1,187,500
+2.6%
0.12%
+5.4%
ZEAL NewZEALAND PHARMA A Ssponsored adr$12,480,000650,000
+100.0%
0.11%
ZGNX BuyZOGENIX INC$11,216,000
+341.9%
320,000
+82.9%
0.10%
+284.6%
CLLS NewCELLECTIS S Asponsored ads$10,953,000385,000
+100.0%
0.10%
MON SellMONSANTO CO NEW$10,784,000
-57.6%
90,000
-58.1%
0.10%
-63.6%
WGL  WGL HLDGS INC$10,104,000
+0.9%
120,0000.0%0.09%
-13.5%
CYOU BuyCHANGYOU COM LTDads rep cl a$9,506,000
+52.5%
240,000
+49.2%
0.08%
+29.2%
ANAB NewANAPTYSBIO INC$8,598,000246,000
+100.0%
0.08%
NCNA NewNUCANA PLCsponsored adr$7,348,000400,000
+100.0%
0.06%
MRNS NewMARINUS PHARMACEUTICALS INC$6,868,0001,170,000
+100.0%
0.06%
SellSOLARCITY CORPnote 2.750%11/0$6,743,000
-46.0%
6,765,000
-45.9%
0.06%
-53.8%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$6,588,000850,000
+100.0%
0.06%
PCO  PENDRELL CORPcl a new$5,608,000
-5.5%
821,0610.0%0.05%
-19.4%
QCOM  QUALCOMM INC$4,406,000
-6.1%
85,0000.0%0.04%
-20.4%
VYGR NewVOYAGER THERAPEUTICS INC$3,452,000167,665
+100.0%
0.03%
BKD  BROOKDALE SR LIVING INC$3,498,000
-27.9%
330,0000.0%0.03%
-38.0%
GCVRZ  SANOFIright 12/31/2020$2,458,000
-5.3%
6,827,8050.0%0.02%
-18.5%
KALA NewKALA PHARMACEUTICALS INC$2,284,000100,000
+100.0%
0.02%
DCPH NewDECIPHERA PHARMACEUTICALS IN$1,899,000100,000
+100.0%
0.02%
NITE NewNIGHTSTAR THERAPEUTICS PLCadr$774,00040,300
+100.0%
0.01%
TOCA ExitTOCAGEN INC$0-100,000
-100.0%
-0.01%
ExitGNC HLDGS INCnote 1.500% 8/1$0-2,700,000
-100.0%
-0.02%
IMGN ExitIMMUNOGEN INC$0-505,000
-100.0%
-0.04%
AMRN ExitAMARIN CORP PLCspons adr new$0-1,495,000
-100.0%
-0.06%
HZNP ExitHORIZON PHARMA PLC$0-745,000
-100.0%
-0.09%
TGNA ExitTEGNA INC$0-670,000
-100.0%
-0.10%
KATE ExitKATE SPADE & CO$0-530,000
-100.0%
-0.10%
RXDX ExitIGNYTA INC$0-1,153,500
-100.0%
-0.12%
PTLA ExitPORTOLA PHARMACEUTICALS INCput$0-250,000
-100.0%
-0.15%
H ExitHYATT HOTELS CORP$0-265,000
-100.0%
-0.16%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-200,000
-100.0%
-0.17%
NVET ExitNEXVET BIOPHARMA PUB LTD CO$0-2,648,696
-100.0%
-0.18%
SHPG ExitSHIRE PLCsponsored adr$0-108,500
-100.0%
-0.19%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-213,000
-100.0%
-0.19%
AKAOQ ExitACHAOGEN INC$0-948,500
-100.0%
-0.21%
TRCO ExitTRIBUNE MEDIA COcl a$0-735,000
-100.0%
-0.31%
CAB ExitCABELAS INC$0-605,000
-100.0%
-0.37%
IMMU ExitIMMUNOMEDICS INC$0-4,227,500
-100.0%
-0.39%
WBMD ExitWEBMD HEALTH CORP$0-679,130
-100.0%
-0.41%
HUM ExitHUMANA INC$0-178,500
-100.0%
-0.45%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-855,000
-100.0%
-0.50%
NORD ExitNORD ANGLIA EDUCATION INC$0-1,535,000
-100.0%
-0.52%
AGN ExitALLERGAN PLC$0-227,500
-100.0%
-0.57%
CLVS ExitCLOVIS ONCOLOGY INC$0-610,000
-100.0%
-0.59%
TMH ExitTEAM HEALTH HOLDINGS INC$0-2,298,900
-100.0%
-1.09%
MBBYF ExitMOBILEYE N V AMSTELVEEN$0-5,907,500
-100.0%
-3.85%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
13F-HR/A2024-02-12
SC 13G/A2024-02-01
SC 13G/A2024-01-23

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings